Status:
UNKNOWN
The Therapeutic Effect of the Extracorporeal Shock Wave Therapy on Shoulder Calcific Tendinitis
Lead Sponsor:
Chimei Medical Center
Conditions:
Calcific Tendinitis
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Calcific tendinopathy of the shoulder is often self-limited with a relatively benign clinical course. Therefore, first-line therapy should be conservative and focused on symptom relief. However, studi...
Detailed Description
Calcific tendinopathy of the shoulder is caused by unknown etiology characterized by the formation of calcific deposits in on or several tendons of the rotator cuff muscles: supraspinatus, infraspinat...
Eligibility Criteria
Inclusion
- ．age 20-70 with calcific tendinitis via sonography or x-ray in rotator cuff
Exclusion
- ．no shoulder fracture, no abnormality, gout or autoimmune disease
Key Trial Info
Start Date :
November 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03779919
Start Date
November 18 2018
End Date
May 31 2020
Last Update
December 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ChiMei Medical Center
Tainan, Taiwan